Hiromi Sato

No ORCID on file · 2 papers in corpus

nonrandomized-trial 2014

Identification of a predictive biomarker for the beneficial effect of keishibukuryogan, a kampo (Japanese traditional) medicine, on patients with climacteric syndrome

Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2014/962109

Keishibukuryogan (KBG; Guizhi-Fuling-Wan in Chinese) is one of the Kampo (Japanese traditional) medicines used to treat patients with climacteric syndrome. KBG can be used by patients who cannot undergo hormone replacement therapy due to a …

diagnostic-accuracy 1993

Serum and tissue measurements of CA72-4 in ovarian cancer patients

Gynecologic Oncology ·doi:10.1006/gyno.1993.1026

Serum levels of cancer-associated antigen 72-4 (CA72-4) (tumor-associated glycoprotein 72; TAG-72) from 106 patients with primary ovarian cancer were measured by an immunoradiometric assay employing the monoclonal antibodies (MAbs) B72.3 an…